StockNews.AI
BLFS
StockNews.AI
406 days

BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024

1. BioLife Solutions will release Q3 2024 financial results on Nov 12, 2024. 2. A conference call will follow the earnings release for business updates. 3. The company focuses on bioproduction for cell and gene therapies. 4. Financial results may affect investor sentiment towards BioLife Solutions stocks.

4m saved
Insight
Article

FAQ

Why Neutral?

The upcoming earnings release may provide crucial insights but lacks immediate impact data.

How important is it?

Earnings reports are significant but without prior estimates, the importance is moderate.

Why Short Term?

Earnings releases typically have immediate effects within days or weeks, depending on results.

Related Companies

BLFS
, /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter 2024 financial results will be released after market close on Tuesday, November 12, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update. To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days. About BioLife SolutionsBioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X. Media & Investor Relations At the CompanyTroy WichtermanChief Financial Officer(425) 402-1400[email protected]  InvestorsLHA Investor RelationsJody Cain(310) 691-7100[email protected]  SOURCE BioLife Solutions, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News